Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
2006 ◽
Vol 114
(s185)
◽
pp. 3-7
◽
2015 ◽
Vol 49
(2)
◽
pp. 531-545
◽
Keyword(s):
2010 ◽
Vol 25
(5)
◽
pp. 511-518
◽
Keyword(s):
1996 ◽
Vol 165
(2)
◽
pp. 77-80
◽
Keyword(s):
1999 ◽
Vol 1454
(1)
◽
pp. 89-96
◽
Keyword(s):
1999 ◽
Vol 27
(5-6)
◽
pp. 544-553
◽
Keyword(s):
1998 ◽
Vol 338
(8)
◽
pp. 506-511
◽
Keyword(s):